Are you Dr. Blostein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
McGill University Faculty of Medicine
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1998
Clinical Trials
- PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin. Start of enrollment: 2006 Dec 01
- Perioperative Anticoagulant Use for Surgery Evaluation Study Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- Extracellular RNA Induces Neutrophil Recruitment Via Toll-Like Receptor 3 During Venous Thrombosis After Vascular Injury.Maria Y Najem, Ryan N Rys, Sandrine Laurance, François-René Bertin, Virginie Gourdou-Latyszenok
Journal of the American Heart Association. 2024-08-06 - 9 citationsCost-effectiveness of eltrombopag versus intravenous immunoglobulin for the perioperative management of immune thrombocytopenia.Manraj Kaur, Donald M. Arnold, Nancy M. Heddle, Richard J. Cook, Cyrus C. Hsia
Blood Advances. 2021-11-15 - 34 citationsPostoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J. Kovacs, Philip S. Wells, David Anderson, Alejandro Lazo-Langner, Clive Kearon
BMJ. 2021-06-09